alpha-2/beta-1 integrin antagonists (BioTie)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namealpha-2/beta-1 integrin antagonists (BioTie)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCoagulation factor inhibitorsIntegrin alpha2/beta1 antagonists
TargetsIntegrin alpha2/beta1Coagulation factor
Therapy Area/IndicationsInflammationThrombosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFinland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiotie Therapies Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiotie Therapies Corp
Active IndicationsN/A
Inactive IndicationsInflammationThrombosisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A